Amgen Financial Statements From 2010 to 2026

Amgen Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 110.9 B 105.6 B 69.9 B Slightly volatile Short and Long Term Debt Total 72.6 B 69.1 B 38.1 B Slightly volatile Other Current Liabilities 21.3 B 20.3 B 9.3 B Slightly volatile Total Current Liabilities 27.9 B 26.6 B 12.9 B Slightly volatile Total Stockholder Equity 11.8 B 6.8 B 14.2 B Slightly volatile Property Plant And Equipment Net 7.9 B 7.5 B 5.3 B Slightly volatile Cash 14.5 B 13.8 B 6.8 B Slightly volatile Non Current Assets Total 75.8 B 72.2 B 40.4 B Slightly volatile Non Currrent Assets Other 12 B 11.4 B 4.5 B Slightly volatile Cash And Short Term Investments 10.3 B 13.8 B 18.6 B Slightly volatile Net Receivables 9.1 B 8.6 B 4.6 B Slightly volatile Common Stock Shares Outstanding 733.7 M 486.9 M 667.5 M Slightly volatile Liabilities And Stockholders Equity 110.9 B 105.6 B 69.9 B Slightly volatile Non Current Liabilities Total 75.9 B 72.3 B 43 B Slightly volatile Other Current Assets 3.1 B 2.9 B 1.9 B Slightly volatile Total Liabilities 103.8 B 98.9 B 55.9 B Slightly volatile Property Plant And Equipment Gross 20.4 B 19.5 B 9 B Slightly volatile Total Current Assets 35.1 B 33.4 B 29.5 B Pretty Stable Short Term Debt 4.3 B 4.1 B 2.1 B Slightly volatile Inventory 8.5 B 8 B 4.2 B Slightly volatile Accounts Payable 2.3 B 2.2 B 1.3 B Slightly volatile Common Stock Total Equity 27.1 B 37.4 B 29.4 B Slightly volatile Short Term Investments 12.2 B 12.6 B 14.9 B Slightly volatile Capital Stock 27.8 B 38.6 B 29.7 B Slightly volatile Common Stock 27.8 B 38.6 B 29.7 B Slightly volatile Other Assets 1.4 B 2.5 B 1.9 B Pretty Stable Long Term Debt 68.3 B 65 B 36 B Slightly volatile Property Plant Equipment 5.3 B 6.2 B 5 B Slightly volatile Good Will 14.7 B 21.4 B 15.1 B Slightly volatile Intangible Assets 33.4 B 31.9 B 16.4 B Slightly volatile Other Liabilities 5.1 B 9.1 B 6.5 B Slightly volatile Long Term Debt Total 29.9 B 43 B 30.4 B Slightly volatile Non Current Liabilities Other 5.2 B 2.7 B 4.8 B Very volatile Long Term Investments 810.9 M 918.9 M 719.7 M Slightly volatile Short and Long Term Debt 1.6 B 3.2 B 1.7 B Slightly volatile Net Invested Capital 54.7 B 75.9 B 56 B Very volatile Net Working Capital 5.1 B 5.3 B 23.8 B Slightly volatile
Amgen Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 6.8 B 6.4 B 2.9 B Slightly volatile Interest Expense 3.8 B 3.6 B 1.6 B Slightly volatile Selling General Administrative 2.7 B 2.7 B 4 B Very volatile Total Revenue 40.4 B 38.4 B 23.8 B Slightly volatile Gross Profit 24.8 B 23.7 B 17.6 B Slightly volatile Other Operating Expenses 31.6 B 30.1 B 16.2 B Slightly volatile EBITDA 16.1 B 15.4 B 10.6 B Slightly volatile Total Operating Expenses 16.1 B 15.3 B 10 B Slightly volatile Income Before Tax 4 B 5.3 B 6.4 B Pretty Stable Net Income 3.2 B 4.7 B 5.3 B Pretty Stable Income Tax Expense 823.2 M 596.9 M 1.2 B Very volatile Research Development 7.2 B 6.9 B 4.4 B Slightly volatile Net Income Applicable To Common Shares 5 B 7.5 B 5.7 B Slightly volatile Net Income From Continuing Ops 6.3 B 4.7 B 5.8 B Slightly volatile Tax Provision 443.7 M 467.1 M 1.3 B Pretty Stable Interest Income 218.9 M 230.4 M 450.9 M Slightly volatile Selling And Marketing Expenses 5.7 B 5.4 B 1.4 B Slightly volatile Reconciled Depreciation 3.5 B 6.4 B 2.9 B Slightly volatile Non Recurring 1.2 B 1.4 B 1.5 B Slightly volatile
Amgen Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 13.2 B 12.6 B 6.1 B Slightly volatile Depreciation 6.8 B 6.4 B 2.9 B Slightly volatile Capital Expenditures 678.3 M 1.3 B 768.9 M Slightly volatile End Period Cash Flow 14.5 B 13.8 B 6.8 B Slightly volatile Dividends Paid 3 B 5.6 B 3.1 B Slightly volatile Change To Operating Activities 637.1 M 1.2 B 711.3 M Pretty Stable
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 8.9 4.85 5.6197 Very volatile Dividend Yield 0.0191 0.0308 0.0231 Slightly volatile PTB Ratio 22.67 21.59 13.0234 Slightly volatile Days Sales Outstanding 47.86 73.72 63.4038 Slightly volatile Book Value Per Share 10.23 9.78 19.5758 Slightly volatile Stock Based Compensation To Revenue 0.0185 0.0182 0.0166 Slightly volatile Capex To Depreciation 0.21 0.23 0.6413 Slightly volatile PB Ratio 22.67 21.59 13.0234 Slightly volatile EV To Sales 9.34 6.51 6.633 Slightly volatile Inventory Turnover 2.67 2.11 3.5047 Slightly volatile Net Income Per Share 7.14 6.8 8.2373 Slightly volatile Days Of Inventory On Hand 218 179 253 Very volatile Payables Turnover 3.06 6.07 4.3339 Slightly volatile Research And Ddevelopement To Revenue 0.22 0.21 0.1901 Very volatile Capex To Revenue 0.0358 0.0377 0.0689 Slightly volatile Cash Per Share 10.1 19.92 26.2298 Pretty Stable Interest Coverage 2.51 2.65 6.001 Slightly volatile Payout Ratio 1.12 1.06 0.6084 Slightly volatile Days Payables Outstanding 59.17 62.29 85.3646 Slightly volatile Income Quality 2.65 2.53 1.8188 Slightly volatile ROE 0.66 0.63 0.5546 Slightly volatile PE Ratio 75.41 39.65 51.981 Slightly volatile Return On Tangible Assets 0.12 0.0809 0.1393 Pretty Stable Earnings Yield 0.0302 0.0261 0.0452 Pretty Stable Intangibles To Total Assets 0.47 0.58 0.4394 Slightly volatile Current Ratio 1.37 1.45 3.5684 Slightly volatile Receivables Turnover 7.4 5.12 6.1068 Slightly volatile Graham Number 26.35 38.69 55.15 Pretty Stable Shareholders Equity Per Share 10.22 9.78 19.5653 Slightly volatile Debt To Equity 9.66 9.2 4.3133 Slightly volatile Capex Per Share 1.91 1.82 1.2345 Slightly volatile Revenue Per Share 58.38 55.6 36.6014 Slightly volatile Interest Debt Per Share 110 105 61.4468 Slightly volatile Debt To Assets 0.62 0.59 0.4993 Slightly volatile Enterprise Value Over EBITDA 15.47 16.28 19.0359 Slightly volatile Price Earnings Ratio 75.41 39.65 51.981 Slightly volatile Operating Cycle 255 253 315 Pretty Stable Price Book Value Ratio 22.67 21.59 13.0234 Slightly volatile Days Of Payables Outstanding 59.17 62.29 85.3646 Slightly volatile Dividend Payout Ratio 1.12 1.06 0.6084 Slightly volatile Pretax Profit Margin 0.24 0.12 0.2799 Very volatile Effective Tax Rate 0.22 0.13 0.1653 Very volatile Company Equity Multiplier 14.77 14.06 7.3943 Slightly volatile Long Term Debt To Capitalization 0.86 0.82 0.6668 Slightly volatile Total Debt To Capitalization 0.86 0.82 0.677 Slightly volatile Debt Equity Ratio 9.66 9.2 4.3133 Slightly volatile Quick Ratio 1.04 1.1 3.2539 Slightly volatile Net Income Per E B T 0.64 0.8 0.8224 Pretty Stable Cash Ratio 0.57 0.6 1.3484 Slightly volatile Cash Conversion Cycle 168 204 233 Pretty Stable Days Of Inventory Outstanding 218 179 253 Very volatile Days Of Sales Outstanding 47.86 73.72 63.4038 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.64 0.81 1.3233 Slightly volatile Price To Book Ratio 22.67 21.59 13.0234 Slightly volatile Fixed Asset Turnover 2.33 4.6 4.1147 Slightly volatile Enterprise Value Multiple 15.47 16.28 19.0359 Slightly volatile Debt Ratio 0.62 0.59 0.4993 Slightly volatile Price Sales Ratio 8.9 4.85 5.6197 Very volatile Return On Assets 0.0487 0.0512 0.0775 Very volatile Asset Turnover 0.51 0.42 0.3462 Slightly volatile Net Profit Margin 0.18 0.11 0.2285 Very volatile Gross Profit Margin 0.64 0.55 0.7796 Slightly volatile Price Fair Value 22.67 21.59 13.0234 Slightly volatile Return On Equity 0.66 0.63 0.5546 Slightly volatile
Amgen Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 121.6 B 115.8 B 114.5 B Slightly volatile Enterprise Value 53.9 B 51.4 B 53.2 B Slightly volatile

Amgen Fundamental Market Drivers

Amgen Upcoming Events

About Amgen Financial Statements

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:

How To Invest In Amgen Details

Is Amgen Stock a good investment? Details

What is Amgen's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details